David R Guyer insider trades: EyePoint Pharmaceuticals (EYPT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
54 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 12, 2024 | EYPT | ↓ Sell | 11,625 | $10.06 | $117K | Direct | Jul 16, 2024 (4d) |
| Jun 3, 2024 | EYPT | ↓ Sell | 11,625 | $10.30 | $120K | Direct | Jun 4, 2024 (1d) |
| May 14, 2024 | EYPT | ↓ Sell | 11,625 | $12.65 | $147K | Direct | May 16, 2024 (2d) |
| Dec 14, 2020 | ISEE | ↓ Sell | 9,270 | $7.16 | $66K | Direct | Dec 15, 2020 (1d) |
| Dec 10, 2020 | ISEE | ↓ Sell | 9,602 | $6.96 | $67K | Direct | Dec 11, 2020 (1d) |
| Jan 6, 2020 | ISEE | ↓ Sell | 3,367 | $8.07 | $27K | Direct | Jan 7, 2020 (1d) |
| Dec 13, 2019 | ISEE | ↓ Sell | 9,275 | $6.60 | $61K | Direct | Dec 16, 2019 (3d) |
| Jan 7, 2019 | OPHT | ↓ Sell | 3,859 | $1.30 | $5K | Direct | Jan 7, 2019 (0d) |
| Jan 3, 2019 | OPHT | ↓ Sell | 3,637 | $1.24 | $5K | Direct | Jan 4, 2019 (1d) |
| Jan 5, 2018 | OPHT | ↓ Sell | 3,798 | $3.17 | $12K | Direct | Jan 5, 2018 (0d) |
| Jan 3, 2018 | OPHT | ↓ Sell | 3,516 | $3.24 | $11K | Direct | Jan 4, 2018 (1d) |
| Jan 2, 2018 | OPHT | ↓ Sell | 16,520 | $3.19 | $53K | Direct | Jan 3, 2018 (1d) |
| Jul 5, 2017 | OPHT | ↓ Sell | 17,678 | $2.58 | $46K | Direct | Jul 5, 2017 (0d) |
| Jan 5, 2017 | OPHT | ↓ Sell | 3,785 | $4.96 | $19K | Direct | Jan 6, 2017 (1d) |
| Jan 3, 2017 | OPHT | ↓ Sell | 3,484 | $4.90 | $17K | Direct | Jan 4, 2017 (1d) |
| Nov 1, 2016 | OPHT | ↓ Sell | 22,060 | $35.61 | $786K | Direct | Nov 3, 2016 (2d) |
| Oct 3, 2016 | OPHT | ↓ Sell | 22,060 | $44.37 | $979K | Direct | Oct 5, 2016 (2d) |
| Sep 1, 2016 | OPHT | ↓ Sell | 24,060 | $52.58 | $1.3M | Direct | Sep 6, 2016 (5d) |
| Aug 1, 2016 | OPHT | ↓ Sell | 24,060 | $64.47 | $1.6M | Direct | Aug 3, 2016 (2d) |
| Jul 1, 2016 | OPHT | ↓ Sell | 24,060 | $52.12 | $1.3M | Direct | Jul 6, 2016 (5d) |
| Jun 1, 2016 | OPHT | ↓ Sell | 30,060 | $52.71 | $1.6M | Direct | Jun 3, 2016 (2d) |
| May 2, 2016 | OPHT | ↓ Sell | 22,060 | $46.18 | $1.0M | Direct | May 4, 2016 (2d) |
| Apr 1, 2016 | OPHT | ↓ Sell | 22,060 | $44.11 | $973K | Direct | Apr 5, 2016 (4d) |
| Mar 1, 2016 | OPHT | ↓ Sell | 22,060 | $45.48 | $1.0M | Direct | Mar 3, 2016 (2d) |
| Jan 28, 2016 | OPHT | ↓ Sell | 18,598 | $53.63 | $997K | Direct | Feb 1, 2016 (4d) |
| Jan 4, 2016 | OPHT | ↓ Sell | 3,269 | $72.54 | $237K | Direct | Jan 5, 2016 (1d) |
| Dec 30, 2015 | OPHT | ↓ Sell | 18,582 | $78.82 | $1.5M | Direct | Jan 4, 2016 (5d) |
| Nov 30, 2015 | OPHT | ↓ Sell | 18,582 | $62.49 | $1.2M | Direct | Dec 2, 2015 (2d) |
| Oct 30, 2015 | OPHT | ↓ Sell | 18,582 | $49.88 | $927K | Direct | Nov 3, 2015 (4d) |
| Sep 29, 2015 | OPHT | ↓ Sell | 18,582 | $37.69 | $700K | Direct | Sep 30, 2015 (1d) |
| Aug 31, 2015 | OPHT | ↓ Sell | 18,582 | $44.88 | $834K | Direct | Sep 2, 2015 (2d) |
| Jul 30, 2015 | OPHT | ↓ Sell | 18,582 | $66.32 | $1.2M | Direct | Aug 3, 2015 (4d) |
| Jun 29, 2015 | OPHT | ↓ Sell | 18,582 | $51.05 | $949K | Direct | Jul 1, 2015 (2d) |
| May 28, 2015 | OPHT | ↓ Sell | 18,582 | $48.62 | $904K | Direct | Jun 1, 2015 (4d) |
| Apr 29, 2015 | OPHT | ↓ Sell | 18,582 | $48.45 | $900K | Direct | Apr 30, 2015 (1d) |
| Mar 30, 2015 | OPHT | ↓ Sell | 18,582 | $48.26 | $897K | Direct | Mar 31, 2015 (1d) |
| Mar 2, 2015 | OPHT | ↓ Sell | 18,582 | $53.22 | $989K | Direct | Mar 3, 2015 (1d) |
| Feb 2, 2015 | OPHT | ↓ Sell | 15,018 | $53.20 | $799K | Direct | Feb 4, 2015 (2d) |
| Jan 2, 2015 | OPHT | ↓ Sell | 15,034 | $45.34 | $682K | Direct | Jan 6, 2015 (4d) |
| Dec 1, 2014 | OPHT | ↓ Sell | 15,034 | $41.58 | $625K | Direct | Dec 3, 2014 (2d) |
| Nov 3, 2014 | OPHT | ↓ Sell | 15,034 | $39.71 | $597K | Direct | Nov 4, 2014 (1d) |
| Oct 2, 2014 | OPHT | ↓ Sell | 2,807 | $38.52 | $108K | Direct | Oct 3, 2014 (1d) |
| Oct 1, 2014 | OPHT | ↓ Sell | 12,227 | $37.30 | $456K | Direct | Oct 3, 2014 (2d) |
| Sep 4, 2014 | OPHT | ↓ Sell | 1,107 | $38.58 | $43K | Direct | Sep 8, 2014 (4d) |
| Sep 2, 2014 | OPHT | ↓ Sell | 12,727 | $37.68 | $480K | Direct | Sep 4, 2014 (2d) |
| Aug 1, 2014 | OPHT | ↓ Sell | 13,136 | $37.85 | $497K | Direct | Aug 4, 2014 (3d) |
| Jul 1, 2014 | OPHT | ↓ Sell | 15,034 | $41.08 | $618K | Direct | Jul 3, 2014 (2d) |
| Jun 2, 2014 | OPHT | ↓ Sell | 25,417 | $39.92 | $1.0M | Direct | Jun 4, 2014 (2d) |
| May 1, 2014 | OPHT | ↓ Sell | 10,665 | $33.71 | $360K | Direct | May 5, 2014 (4d) |
| Apr 1, 2014 | OPHT | ↓ Sell | 12,027 | $34.27 | $412K | Direct | Apr 3, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EYPT insiders
Open-market trades in the last 12 months
About David R Guyer's insider trades
David R Guyer is an insider at EyePoint Pharmaceuticals (EYPT). Since Jun 1, 2005, David has reported no open-market purchases and 54 sales worth $31.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
3 sales (2% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (51 filings), grants and awards (19 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EYPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.